Stitt J. Urticaria and Angioedema. Immunol Allergy Clin North Am. 2024 Aug;44(3):xv-xvi. PubMed PMID: 38937018
Keller L, Stitt J. Chronic Spontaneous Urticaria: Quality of Life and Economic Impacts. Immunol Allergy Clin North Am. 2024 Aug;44(3):453-467. PubMed PMID: 38937009
Keller L, Perera EK, Bindon B, Khatiwada A, Stitt JM, Dreskin SC. Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis. Allergy Asthma Proc. 2024 Mar 1;45(2):97-99. PubMed PMID: 38449010
Dreskin SC and Stitt JM. Anaphylaxis. In: Middleton’s Allergy, Principles and Practice, 9th edition. Adkinson, NF, Bochner B, Burks WA, Busse W, Holgate S. Mosby. 2019.
Stitt JM, Dzieciatkowska M, Edwards MG, Hansen K, Hedlund G, Dreskin SC. The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders. Clin Exp Allergy. 2018 Jul;48(7):898-901. PubMed PMID: 29671921
Stitt JM, Dreskin SC. The potential role of omalizumab in the treatment of chronic urticaria. Immunotherapy. 2014 Jun;6(6):691-7. PubMed PMID: 25186602
Stitt JM, Dreskin SC. Urticaria and autoimmunity: where are we now?. Curr Allergy Asthma Rep. 2013 Oct;13(5):555-62. PubMed PMID: 23821106